Role of receptor tyrosine kinases in lung cancer.
Methods Mol Med
; 74: 113-25, 2003.
Article
em En
| MEDLINE
| ID: mdl-12415690
ABSTRACT
Receptor tyrosine kinases are important in normal cellular physiology as well in the pathogenesis of a variety of tumors, including lung cancer. RTKs are a target for novel therapies currently being investigated. In the clinics, EGFR inhibitors and c-Kit inhibitors are already being utilized, and c-Met inhibitors are in development. Even though the RTK inhibitors provide a novel mechanism, it is important to realize that lung cancer etiology is a complex process, and eventually standard chemotherapy may need to be used in conjunction with these novel therapies to make an important difference in response rates.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Receptores Proteína Tirosina Quinases
/
Carcinoma de Células Pequenas
/
Carcinoma Pulmonar de Células não Pequenas
/
Neoplasias Pulmonares
Limite:
Animals
/
Humans
Idioma:
En
Ano de publicação:
2003
Tipo de documento:
Article